PPA
7
2
2
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
14.3%
1 terminated out of 7 trials
66.7%
-19.9% vs benchmark
14%
1 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Nabilone for Agitation in Frontotemporal Dementia
Personalized Closed-Loop Brain Stimulation for Patients With Primary Progressive Aphasia
Repetitive Transcranial Magnetic Stimulation in Frontotemporal Lobar Degeneration
Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders
Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech
Rehabilitating and Decelerating Language Loss in Primary Progressive Aphasia With tDCS Plus Language Therapy
PiB PET Scanning in Speech and Language Based Dementias